Aggressive Coronary Artery Vasculopathy after Combined Heart-Lung Transplantation

被引：0

作者：

Hayes, Don, Jr. ^{[1
,2
]}

Baker, Peter B. ^{[1
,2
]}

Astor, Todd L. ^{[3
]}

Preston, Thomas J. ^{[2
]}

Kirkby, Stephen ^{[1
,2
]}

Galantowicz, Mark ^{[1
,2
]}

Hoffman, Timothy M. ^{[1
,2
]}

机构：

[1] Nationwide Childrens Hosp, Columbus, OH USA

[2] Ohio State Univ, Coll Med, Columbus, OH 43210 USA

[3] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

CONGENITAL HEART DISEASE | 2013年 / 8卷 / 03期

关键词：

Allograft Rejection; Bronchiolitis Obliterans Syndrome; Combined Heart and Lung Transplantation; Coronary Artery Vasculopathy;

D O I：

10.1111/j.1747-0803.2012.00681.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Combined heart-lung transplantation remains as a treatment option for patients with cardiopulmonary failure. There is speculation that lung grafts protect the heart from developing graft vasculopathy after combined heart-lung transplantation. This protective mechanism is more likely, at best, a delay in the onset of coronary artery vasculopathy. We present our experiences in two cases of an aggressive form of cardiac allograft vasculopathy after combined heart-lung transplantation that resulted in the death of both patients.

引用

页码：E88 / E91

页数：4

共 5 条

[1]

Christie J.D., Edwards L.B., Kucheryavaya A.Y., Et al., The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010, J Heart Lung Transplant, 29, pp. 1104-1118, (2010)

[2]

Stehlik J., Edwards L.B., Kucheryavaya A.Y., Et al., The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010, J Heart Lung Transplant, 29, pp. 1089-1103, (2010)

[3]

Moffatt-Bruce S.D., Karamichalis J., Robbins R.C., Whyte R.I., Theodore J., Reitz B.A., Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?, Ann Thorac Surg, 81, pp. 286-291, (2006)

[4]

Deuse T., Sista R., Weill D., Et al., Review of heart-lung transplantation at Stanford, Ann Thorac Surg, 90, pp. 329-337, (2010)

[5]

Vamvakopoulos J.E., Taylor C.J., Green C., Et al., Interleukin 1 and chronic rejection: possible genetic links in human heart allografts, Am J Transplant, 2, pp. 76-83, (2002)

← 1 →